ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/10/23 | 1,845 | 1,866 | 1,839 | 1,840 | -1 | -0.1% | 29,200 |
2020/10/22 | 1,876 | 1,876 | 1,841 | 1,841 | -35 | -1.9% | 41,800 |
2020/10/21 | 1,850 | 1,895 | 1,850 | 1,876 | +29 | +1.6% | 29,900 |
2020/10/20 | 1,887 | 1,887 | 1,847 | 1,847 | -39 | -2.1% | 47,000 |
2020/10/19 | 1,878 | 1,910 | 1,878 | 1,886 | +12 | +0.6% | 35,200 |
2020/10/16 | 1,890 | 1,899 | 1,871 | 1,874 | -26 | -1.4% | 29,400 |
2020/10/15 | 1,922 | 1,934 | 1,896 | 1,900 | -41 | -2.1% | 38,100 |
2020/10/14 | 1,957 | 1,977 | 1,937 | 1,941 | -27 | -1.4% | 24,900 |
2020/10/13 | 1,987 | 1,987 | 1,957 | 1,968 | -21 | -1.1% | 31,800 |
2020/10/12 | 1,988 | 1,994 | 1,961 | 1,989 | +14 | +0.7% | 31,900 |
2020/10/09 | 2,004 | 2,005 | 1,968 | 1,975 | -29 | -1.4% | 31,500 |
2020/10/08 | 2,009 | 2,017 | 1,996 | 2,004 | +13 | +0.7% | 41,900 |
2020/10/07 | 1,999 | 2,004 | 1,977 | 1,991 | -18 | -0.9% | 35,700 |
2020/10/06 | 1,991 | 2,013 | 1,973 | 2,009 | +17 | +0.9% | 25,400 |
2020/10/05 | 1,984 | 2,018 | 1,982 | 1,992 | +29 | +1.5% | 38,500 |
2020/10/02 | 2,010 | 2,033 | 1,950 | 1,963 | - | - | 45,100 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 2,070 | 2,078 | 2,009 | 2,010 | -56 | -2.7% | 48,100 |
2020/09/29 | 2,069 | 2,080 | 2,020 | 2,066 | -24 | -1.1% | 89,000 |
2020/09/28 | 2,056 | 2,090 | 2,039 | 2,090 | +54 | +2.7% | 254,000 |
2020/09/25 | 2,074 | 2,098 | 2,032 | 2,036 | -21 | -1% | 153,400 |
2020/09/24 | 2,056 | 2,085 | 2,056 | 2,057 | -6 | -0.3% | 62,300 |
2020/09/23 | 2,049 | 2,076 | 2,048 | 2,063 | -1 | ±0% | 73,500 |
2020/09/18 | 2,053 | 2,067 | 2,026 | 2,064 | +16 | +0.8% | 80,500 |
2020/09/17 | 2,074 | 2,074 | 2,020 | 2,048 | -20 | -1% | 43,800 |
2020/09/16 | 2,028 | 2,069 | 2,025 | 2,068 | +53 | +2.6% | 47,700 |
2020/09/15 | 2,057 | 2,057 | 2,015 | 2,015 | -38 | -1.9% | 32,200 |
2020/09/14 | 2,036 | 2,065 | 2,033 | 2,053 | +24 | +1.2% | 48,200 |
2020/09/11 | 2,017 | 2,029 | 1,980 | 2,029 | +24 | +1.2% | 76,200 |
2020/09/10 | 1,990 | 2,016 | 1,990 | 2,005 | +24 | +1.2% | 69,300 |
2020/09/09 | 1,960 | 1,987 | 1,960 | 1,981 | -7 | -0.4% | 53,100 |
2020/09/08 | 1,960 | 1,988 | 1,954 | 1,988 | +28 | +1.4% | 47,100 |
2020/09/07 | 1,948 | 1,985 | 1,937 | 1,960 | +5 | +0.3% | 41,000 |
2020/09/04 | 1,928 | 1,965 | 1,919 | 1,955 | +12 | +0.6% | 32,900 |
2020/09/03 | 1,967 | 1,967 | 1,931 | 1,943 | -13 | -0.7% | 49,300 |
2020/09/02 | 1,975 | 1,975 | 1,945 | 1,956 | -19 | -1% | 27,600 |
2020/09/01 | 1,967 | 1,999 | 1,962 | 1,975 | +15 | +0.8% | 27,000 |
2020/08/31 | 1,972 | 1,987 | 1,944 | 1,960 | +8 | +0.4% | 43,400 |
2020/08/28 | 1,954 | 1,997 | 1,934 | 1,952 | +2 | +0.1% | 63,800 |
2020/08/27 | 1,946 | 1,950 | 1,929 | 1,950 | +4 | +0.2% | 20,400 |
2020/08/26 | 1,947 | 1,961 | 1,934 | 1,946 | -12 | -0.6% | 22,000 |
2020/08/25 | 1,966 | 1,967 | 1,947 | 1,958 | +7 | +0.4% | 24,900 |
2020/08/24 | 1,931 | 1,951 | 1,920 | 1,951 | +14 | +0.7% | 21,400 |
2020/08/21 | 1,928 | 1,951 | 1,918 | 1,937 | +20 | +1% | 15,200 |
2020/08/20 | 1,931 | 1,937 | 1,910 | 1,917 | -32 | -1.6% | 30,900 |
2020/08/19 | 1,963 | 1,963 | 1,946 | 1,949 | -19 | -1% | 16,100 |
2020/08/18 | 1,962 | 1,991 | 1,962 | 1,968 | -2 | -0.1% | 29,400 |
2020/08/17 | 1,989 | 1,989 | 1,959 | 1,970 | -22 | -1.1% | 15,900 |
2020/08/14 | 1,990 | 2,010 | 1,985 | 1,992 | +5 | +0.3% | 39,500 |
2020/08/13 | 1,972 | 1,996 | 1,957 | 1,987 | +19 | +1% | 51,100 |
1001~
1050
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム